Free Trial
LON:VRP

Verona Pharma plc (VRP.L) (VRP) Share Price, News & Analysis

Verona Pharma plc (VRP.L) logo
GBX 55
+3.00 (+5.77%)
(As of 10/29/2020)

About Verona Pharma plc (VRP.L) (LON:VRP)

Key Stats

Today's Range
50
56
50-Day Range
55
55
52-Week Range
28.60
115
Volume
70,791 shs
Average Volume
150,610 shs
Market Capitalization
£228.00 million
Assets Under Management
N/A
Dividend Yield
N/A
Net Expense Ratio
0.00%
Aggregate Rating
N/A

ETF Overview

Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis. Verona Pharma plc was founded in 2005 and is headquartered in London, the United Kingdom.

Receive VRP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Verona Pharma plc (VRP.L) and its competitors with MarketBeat's FREE daily newsletter.

VRP ETF News Headlines

Verona Pharma Q3 2024 Earnings Preview
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Piper Sandler Remains a Buy on Verona Pharma (VRNA)
See More Headlines

VRP ETF - Frequently Asked Questions

Verona Pharma plc (VRP.L)'s stock was trading at GBX 55 on January 1st, 2024. Since then, VRP shares have increased by 0.0% and is now trading at GBX 55.
View the best growth stocks for 2024 here
.

Verona Pharma plc (VRP.L) (LON:VRP) issued its earnings results on Thursday, February, 27th. The company reported ($30.30) earnings per share (EPS) for the quarter, topping the consensus estimate of ($30.80) by $0.50.

Shares of VRP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Verona Pharma plc (VRP.L) investors own include Verona Pharma (VRNA), Fate Therapeutics (FATE), Pluristem Therapeutics (PSTI), AbbVie (ABBV), BioMarin Pharmaceutical (BMRN), Exelixis (EXEL) and Amicus Therapeutics (FOLD).

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (LON:VRP) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners